Acid sphingomyelinase mediates the noise-induced liver disorder in mice

Clin Exp Pharmacol Physiol. 2019 Jun;46(6):556-566. doi: 10.1111/1440-1681.13083. Epub 2019 Apr 3.

Abstract

Noise-induced structural and functional disorder of the liver has been realized, but the underlying mechanism remains to be characterized, which has limited the introduction of precautious measures. Over-activation of acid sphingomyelinase (ASM)/ceramide (Cer) pathway takes centre stage in hepatocyte injury entailed by various stimulus. We aimed to investigate whether it mediated the noise elicited liver disorder on infrastructure, lipid metabolism, apoptosis, and oxidative stress. Mice were exposed to broad band noise (20-20k Hz, 90-110 dB) for 1, 3, 5 or 7 days by 3 hr/d. Doxepin hydrochloride (DOX), an ASM inhibitor was given by 5 mg/kg/d gavage. We showed that 5 or 7 days intense, broad band noise exposure caused significant infrastructure derangement and lipid droplets storage in hepatocytes. The content of cholesterol, free fatty acids or triglyceride was increased significantly in liver tissue upon noise stimulation. Moreover, the noise promoted apoptosis and superoxide generation in hepatocytes significantly, enhancing activity of aspartate aminotransferase (AST) or alanine amino transferase (ALT) in serum. Acid sphingomyelinase activity and Cer generation in liver tissue were elevated by noise exposure, which was normalized with DOX administrated. Accordingly, DOX alleviated steatosis, apoptosis, oxidative stress and enzymatic change in hepatocytes or serum of noise exposed mice substantially. In summary, our results suggest the ASM/Cer pathway contributes to the broad band noise elicited liver damage in mice.

Keywords: acid sphingomyelinase; ceramide; doxepin hydrochloride; liver; noise; noise-induced liver damage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alanine Transaminase / metabolism
  • Animals
  • Apoptosis / drug effects
  • Aspartate Aminotransferases / metabolism
  • Ceramides / metabolism
  • Doxepin / pharmacology
  • Fibrosis
  • Hepatocytes / drug effects
  • Hepatocytes / metabolism
  • Hepatocytes / pathology
  • Lipid Droplets / drug effects
  • Lipid Droplets / metabolism
  • Liver Diseases / enzymology*
  • Liver Diseases / etiology*
  • Liver Diseases / metabolism
  • Liver Diseases / pathology
  • Male
  • Mice
  • Noise / adverse effects*
  • Oxidative Stress / drug effects
  • Sphingomyelin Phosphodiesterase / metabolism*
  • Time Factors

Substances

  • Ceramides
  • Doxepin
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Sphingomyelin Phosphodiesterase